Galanin receptor/Neuropeptide Y receptor interactions in the dorsal raphe nucleus of the rat

Neuropharmacology

Volumn 61, Issue 1-2, 2011, Pages 80-86

  Díaz Cabiale, Zaida ^a   Parrado, Concepción ^a   Narváez, Manuel ^a   Puigcerver, Araceli ^a   Millón, Carmelo ^a   Santín, Luis ^a   Fuxe, Kjell ^b   Narváez, José Angel ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoradiography; Dorsal raphe nucleus; Galanin; Galanin receptor; NPY Y1 Y5 receptor

Indexed keywords

GALANIN RECEPTOR; LEUCINE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR AGONIST; NEUROPEPTIDE Y5 RECEPTOR AGONIST; PROLINE; PROTEIN C FOS; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAPHE NUCLEUS; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; SEROTONINERGIC NERVE CELL; STEREOLOGY;

ANIMALS; GALANIN; INJECTIONS, INTRAVENTRICULAR; MALE; PROTEIN BINDING; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GALANIN; RECEPTORS, NEUROPEPTIDE Y;

EID: 79957858596     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.03.002     Document Type: Article

References (45)

1. AbdAlla, S., Abdel-Baset, A., Lother, H., el Massiery, A., Quitterer, U., 2005. Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J. Mol. Neurosci. 26, 185-192.
2. Agnati, L.F., Ferre, S., Lluis, C., Franco, R., Fuxe, K., 2003. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509-550.
3. Bartfai, T., Fisone, G., Langel, U., 1992. Galanin and galanin antagonists: molecular and biochemical perspectives. Trends Pharmacol. Sci. 13, 312-317.
4. Borroto-Escuela, D.O., Narvaez, M., Marcellino, D., Parrado, C., Narvaez, J.A., Tarakanov, A.O., Agnati, L.F., Diaz-Cabiale, Z., Fuxe, K., 2010. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem. Biophys. Res. Commun. 393, 767-772.
5. Brain, S.D., Cox, H.M., 2006. Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br. J. Pharmacol. 147 (Suppl. 1), S202-S211.
6. Branchek, T.A., Smith, K.E., Gerald, C., Walker, M.W., 2000. Galanin receptor subtypes. Trends Pharmacol. Sci. 21, 109-117.
7. Caberlotto, L., Fuxe, K., Overstreet, D.H., Gerrard, P., Hurd, Y.L., 1998. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res. Mol. Brain Res. 59, 58-65.
8. Caberlotto, L., Jimenez, P., Overstreet, D.H., Hurd, Y.L., Mathe, A.A., Fuxe, K., 1999. Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive line rats, a genetic animal model of depression. Neurosci. Lett. 265, 191-194.
9. Diaz-Cabiale, Z., Narvaez, J.A., Yanaihara, N., Gonzalez-Baron, S., Fuxe, K., 2000. Galanin/alpha2-receptor interactions in central cardiovascular control. Neuropharmacology 39, 1377-1385. (Pubitemid 30249200)
10. Diaz-Cabiale, Z., Parrado, C., Rivera, A., de la Calle, A., Agnati, L., Fuxe, K., Narvaez, J.A., 2006. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype. Eur. J. Neurosci. 24, 499-508.
11. Dumont, Y., Fournier, A., St-Pierre, S., Quirion, R., 1993. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. 13, 73-86. (Pubitemid 23028729)
12. Durkin, M.M., Walker, M.W., Smith, K.E., Gustafson, E.L., Gerald, C., Branchek, T.A., 2000. Expression of a novel neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brain. Exp. Neurol. 165, 90-100.
13. Endoh, T., Sato, D., Wada, Y., Shibukawa, Y., Ishihara, K., Hashimoto, S., Yoshinari, M., Matsuzaka, K., Tazaki, M., Inoue, T., 2008. Galanin inhibits calcium channels via Galpha(i)-protein mediated by GalR1 in rat nucleus tractus solitarius. Brain Res. 1229, 37-46.
14. Fuxe, K., Jansson, A., Diaz-Cabiale, Z., Andersson, A., Tinner, B., Finnman, U.B., Misane, I., Razani, H., Wang, F.H., Agnati, L.F., Ogren, S.O., 1998. Galanin modulates 5-hydroxytryptamine functions. Focus on galanin and galanin fragment/5-hydroxytryptamine1A receptor interactions in the brain. Ann. N. Y. Acad. Sci. 863, 274-290.
15. Fuxe, K., Marcellino, D., Rivera, A., Diaz-Cabiale, Z., Filip, M., Gago, B., Roberts, D.C., Langel, U., Genedani, S., Ferraro, L., de la Calle, A., Narvaez, J., Tanganelli, S., Woods, A., Agnati, L.F., 2008. Receptorereceptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58, 415-452.
16. Fuxe, K., Ogren, S.O., Jansson, A., Cintra, A., Harfstrand, A., Agnati, L.F., 1988. Intraventricular injections of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male rat. Acta Physiol. Scand. 133, 579-581.
17. Gehlert, D.R., Schober, D.A., Morin, M., Berglund, M.M., 2007. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties. Biochem. Pharmacol. 74, 1652-1664.
18. Gundersen, H.J., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., et al., 1988. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96, 857-881.
19. Harfstrand, A., Fuxe, K., Agnati, L., Fredholm, B., 1989. Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis. J. Neural Transm. 75, 83-99.
20. Heilig, M., 2004. The NPY system in stress, anxiety and depression. Neuropeptides 38, 213-224. (Pubitemid 39158860)
21. Hohmann, J.G., Teklemichael, D.N., Weinshenker, D., Wynick, D., Clifton, D.K., Steiner, R.A., 2004. Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin. Mol. Cell. Biol. 24, 2978-2985.
22. Ishida, H., Shirayama, Y., Iwata, M., Katayama, S., Yamamoto, A., Kawahara, R., Nakagome, K., 2007. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor. Hippocampus 17, 271-280. (Pubitemid 46649579)
23. Jacobowitz, D.M., Kresse, A., Skofitsch, G., 2004. Galanin in the brain: chemoarchitectonics and brain cartographyea historical review. Peptides 25, 433-464. (Pubitemid 38591555)
24. Jimenez-Vasquez, P.A., Diaz-Cabiale, Z., Caberlotto, L., Bellido, I., Overstreet, D., Fuxe, K., Mathe, A.A., 2007. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of flinders sensitive line rat model of depression. Eur. Neuropsychopharmacol. 17, 298-308.
25. Karlsson, R.M., Choe, J.S., Cameron, H.A., Thorsell, A., Crawley, J.N., Holmes, A., Heilig, M., 2008. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl.) 195, 547-557. (Pubitemid 350160495)
26. Kehr, J., Yoshitake, T., Wang, F.H., Razani, H., Gimenez-Llort, L., Jansson, A., Yamaguchi, M., Ogren, S.O., 2002. Galanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmission. Neuropsychopharmacology 27, 341-356. (Pubitemid 35253783)
27. Kuteeva, E., Wardi, T., Hokfelt, T., Ogren, S.O., 2007. Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat. Eur. Neuropsychopharmacol. 17, 64-69.
28. Kuteeva, E., Wardi, T., Lundstrom, L., Sollenberg, U., Langel, U., Hokfelt, T., Ogren, S.O., 2008. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharmacology 33, 2573-2585.
29. Lang, R., Gundlach, A.L., Kofler, B., 2007. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 115, 177-207.
30. Langel, U., Bartfai, T., 1998. Chemistry and molecular biology of galanin receptor ligands. Ann. N. Y. Acad. Sci. 863, 86-93.
31. Leibowitz, S.F., Alexander, J., Dourmashkin, J.T., Hill, J.O., Gayles, E.C., Chang, G.Q., 2005. Phenotypic profile of SWR/J and A/J mice compared to control strains: possible mechanisms underlying resistance to obesity on a high-fat diet. Brain Res. 1047, 137-147. (Pubitemid 40799309)
32. Milligan, G., 2004. G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 66, 1-7.
33. Nakamura, M., Sakanaka, C., Aoki, Y., Ogasawara, H., Tsuji, T., Kodama, H., Matsumoto, T., Shimizu, T., Noma, M., 1995. Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J. Biol. Chem. 270, 30102-30110.
34. Parker, R.M., Herzog, H., 1999. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11, 1431-1448.
35. Parrado, C., Diaz-Cabiale, Z., Garcia-Coronel, M., Agnati, L.F., Covenas, R., Fuxe, K., Narvaez, J.A., 2007. Region specific galanin receptor/ neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption. Neuropharmacology 52, 684-692. (Pubitemid 46123378)
36. Paxinos, G.A.W.C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press Inc, San Diego.
37. Razani, H., Diaz-Cabiale, Z., Fuxe, K., Ogren, S.O., 2000. Intraventricular galanin produces a time-dependent modulation of 5-HT1A receptors in the dorsal raphe of the rat. Neuroreport 11, 3943-3948. (Pubitemid 32038781)
38. Razani, H., Diaz-Cabiale, Z., Misane, I., Wang, F.H., Fuxe, K., Ogren, S.O., 2001. Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine(1A) receptor mediated function in the rat. Neurosci. Lett. 299, 145-149.
39. Rosmaninho-Salgado, J., Araujo, I.M., Alvaro, A.R., Duarte, E.P., Cavadas, C., 2007. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells. J. Neurochem. 103, 896-903. (Pubitemid 47568747)
40. Sharkey, L.M., Madamba, S.G., Siggins, G.R., Bartfai, T., 2008. Galanin alters GABAergic neurotransmission in the dorsal raphe nucleus. Neurochem. Res. 33, 285-291.
41. Skofitsch, G., Sills, M.A., Jacobowitz, D.M., 1986. Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 7, 1029-1042. (Pubitemid 17226730)
42. Tatemoto, K., Rokaeus, A., Jornvall, H., McDonald, T.J., Mutt, V., 1983. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164, 124-128. (Pubitemid 14201839)
43. Vilardaga, J.P., Nikolaev, V.O., Lorenz, K., Ferrandon, S., Zhuang, Z., Lohse, M.J., 2008. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. Nat. Chem. Biol. 4, 126-131.
44. Walton, K.M., Chin, J.E., Duplantier, A.J., Mather, R.J., 2006. Galanin function in the central nervous system. Curr. Opin. Drug Discov. Devel. 9, 560-570.
45. Wirz, S.A., Davis, C.N., Lu, X., Zal, T., Bartfai, T., 2005. Homodimerization and internalization of galanin type 1 receptor in living CHO cells. Neuropeptides 39, 535-546. (Pubitemid 41718978)